Refer A Patient

Request An Appointment

Gastroenterology

STELARA

STELARA (ustekinumab) is an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation.
Infusion or injection therapy referral
What it treats Moderate to severe Plaque Psoriasis, Active Psoriatic Arthritis alone or in combination with Methotrexate, Moderate to severe Crohn's Disease, Ulcerative Colitis (UC)
Prescribed by Dermatologists & Gastroenterologists
How it’s administered Subcutaneous injection or intravenous (IV) infusion, or a combination of both (depending on the diagnosis)
Frequency For psoriasis, every 12 weeks (after two starter doses); for UC and Crohn's disease, every 8 weeks (after an IV starter dose)
Length of treatment 10 minutes or less for subcutaneous injection; about an hour for IV infusion

About This Therapy

STELARA (ustekinumab) is an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation. Specifically, it is an interleukin-12 and -23 antagonist antibody used to treat psoriasis, Crohn’s disease, and Ulcerative Colitis (UC).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

STELARA REFERRAL FORM

STELARA REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for STELARA

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.